Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Change in Accured Expenses (2020 - 2023)

Historic Change in Accured Expenses for Surgery Partners (SGRY) over the last 4 years, with Q1 2023 value amounting to -$1.2 million.

  • Surgery Partners' Change in Accured Expenses rose 9333.33% to -$1.2 million in Q1 2023 from the same period last year, while for Dec 2023 it was -$1.2 million, marking a year-over-year increase of 9794.52%. This contributed to the annual value of -$1.2 million for FY2023, which is 9794.52% up from last year.
  • Per Surgery Partners' latest filing, its Change in Accured Expenses stood at -$1.2 million for Q1 2023, which was up 9333.33% from -$4.7 million recorded in Q4 2022.
  • Surgery Partners' 5-year Change in Accured Expenses high stood at $124.7 million for Q2 2020, and its period low was -$25.1 million during Q4 2021.
  • For the 4-year period, Surgery Partners' Change in Accured Expenses averaged around $166666.7, with its median value being -$10.4 million (2021).
  • In the last 5 years, Surgery Partners' Change in Accured Expenses crashed by 33275.86% in 2021 and then surged by 9333.33% in 2023.
  • Surgery Partners' Change in Accured Expenses (Quarter) stood at -$5.8 million in 2020, then tumbled by 332.76% to -$25.1 million in 2021, then skyrocketed by 81.27% to -$4.7 million in 2022, then surged by 74.47% to -$1.2 million in 2023.
  • Its Change in Accured Expenses stands at -$1.2 million for Q1 2023, versus -$4.7 million for Q4 2022 and -$13.5 million for Q3 2022.